SFX by Ex Libris Inc.

Title:	Association of cdk2 kinase with the transcription factor E2F during S phase
Source:	Science [0036-8075] Pagano, M yr:1992

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Ulrich, E. "Immortalization of conditionally transformed chicken cells: loss of normal p53 expression is an early step that is independent of cell transformation." Genes & development 6.5 (1992): 876-887.
description	2.	Prives, C. "The P53 pathway." The Journal of pathology 187.1 (1999): 112-126.
description	3.	Levine, Philip W J. "P53 is a tumor suppressor gene." Cell 116.2 Suppl (2004): 67-9.
description	4.	Levine, A J J. "p53, the cellular gatekeeper for growth and division." Cell 88.3 (1997): 323-31.
description	5.	Sherr, Charles J. "Cancer Cell Cycles." Science 274.5293 (1996): 1672-1677.
description	6.	Qin, W G Q. "Identification of a growth suppression domain within the retinoblastoma gene product." Genes & development 6.6 (1992): 953-64.
description	7.	Sherr, C J J. "The ARF/p53 pathway." Current opinion in genetics & development 10.1 (2000): 94-99.
description	8.	Vassilev, Lyubomir T. "In vivo activation of the p53 pathway by small-molecule antagonists of MDM2." Science 303.5659 (2004): 844-848.
description	9.	Vogelstein, Bert, B. "Surfing the p53 network." Nature 408.6810 (2000): 307-10.
description	10.	Hollstein, M. "p53 mutations in human cancers." Science 253.5015: 49-53.
description	11.	Hartwell, L H H. "Cell cycle control and cancer." Science 266.5192 (1995): 1821-8.
description	12.	Weinberg, R A A. "the retinoblastoma protein and cell cycle control." Cell 81.3 (1995): 323-330.
description	13.	Finlay, C A A. "The p53 tumour suppressor gene." Nature 351.6326 (1991): 453-6.
description	14.	May, P. "Twenty years of p53 research: structural and functional aspects of the p53 protein." Oncogene 18.53 (2000): 7621-36.
description	15.	Ding, Q. "Discovery of RG7388, a Potent and Selective p53-MDM2 Inhibitor in Clinical Development." Journal of medicinal chemistry 56.14 (2013): 5979-5983.
description	16.	Kim, William Y Y. "The regulation of INK4/ARF in cancer and aging." Cell 127.2 (2006): 265-75.
description	17.	Kinzler, Kenneth W W. "Cancer genes and the pathways they control." Nature medicine 10.8 (2004): 789-99.
description	18.	Tovar, C. "Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapy." Proceedings of the National Academy of Sciences of the United States of America 103.6 (2006): 1888-1893.
description	19.	HOON, S. "Yeast chemical genomics and drug discovery: an update." Trends in Pharmacological Sciences 29.10 (2008): 499-504.
description	20.	Evan, G I I. "Proliferation, cell cycle and apoptosis in cancer." Nature 411.6835 (2001): 342-348.